November 19th, 2026Wen Shen, MD, and Dana Sarnak, PhD, on MHT access and supplyWen Shen, MD, and Dana Sarnak, PhD, on MHT access strains at the pharmacy and the demand forecasting and equity research ahead.Read more
November 18th, 2026Dana Sarnak, PhD, and Wen Shen, MD, on trends in menopause hormone therapyDana Sarnak, PhD, and Wen Shen, MD, comment on a Johns Hopkins analysis showing rising menopause hormone therapy use among midlife women.Read more
November 18th, 2026Liudmila Zhaunova on the case for perimenopause activity trialsZhaunova calls for randomized trials with objective activity measures to confirm a causal effect.Read more
November 16th, 2026Weekly review: Testosterone’s history, Peri-SS symptom scale, and moreGet caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.Read more
November 13th, 2026Testosterone in women: Androgenic adverse events and lab monitoringBlood levels alone cannot confirm safe testosterone dosing. Asking about androgenic effects and allowing months for response are central to care.Read more
November 13th, 2026Testosterone for women: Global consensus and physiologic dosingA global consensus defines what the evidence supports for testosterone in women. Benefits for strength, mood, and cognition lack randomized data.Read more
November 13th, 2026Testosterone physiology in women and the long road to approvalA testosterone patch improved sexual desire in trials but never won US approval. Normal female physiology defines what replacement should target.Read more
November 13th, 2026WHI fallout: How hormone fears stalled testosterone therapy for womenThe WHI never studied testosterone, yet it chilled conversations about every hormone, with lasting consequences for women’s sexual health.Read more